CN Stock MarketDetailed Quotes

301258 Suzhou Fushilai Pharmaceutical

Watchlist

25.02
-1.23-4.69%

Market Closed Aug 9 15:00 CST

2.29BMarket Cap34.56P/E (TTM)

Suzhou Fushilai Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Money funds

38.55%428.08M

34.68%349.74M

11.74%346.81M

-36.26%229M

-76.86%308.97M

-21.79%259.69M

--310.36M

19.78%359.25M

--1.34B

238.51%332.06M

Transactional financial assets

-16.57%969.42M

-7.87%1.07B

-0.25%1.07B

22.87%1.21B

5,103.52%1.16B

5,271.44%1.16B

--1.07B

6,807,930.50%982.63M

--22.33M

-81.99%21.61M

Notes receivable and accounts receivable

-18.65%62.91M

-34.79%60.09M

-6.56%67.63M

-1.90%80.55M

-20.04%77.33M

7.82%92.14M

--72.38M

5.98%82.11M

--96.71M

7.18%85.46M

-Accounts receivable

-18.65%62.91M

-34.79%60.09M

-6.56%67.63M

-1.90%80.55M

-20.04%77.33M

7.82%92.14M

--72.38M

5.98%82.11M

--96.71M

7.18%85.46M

Other receivables (including interest and dividends)

5.28%989.06K

9.33%932.92K

12.18%991.87K

168.95%1.03M

162.71%939.42K

-58.40%853.3K

--884.2K

-35.63%381.35K

--357.58K

41.74%2.05M

-Other receivable

----

168.95%1.03M

----

-58.40%853.3K

----

-35.63%381.35K

----

41.74%2.05M

Advance payment

-21.98%2.88M

-31.85%3.47M

-16.89%2.97M

54.63%4.09M

30.22%3.69M

72.49%5.1M

--3.57M

33.23%2.65M

--2.83M

18.52%2.95M

Inventories

18.22%152.96M

28.04%157.09M

19.16%156.29M

45.43%145.7M

68.83%129.38M

78.85%122.69M

--131.16M

56.58%100.18M

--76.64M

14.11%68.6M

Receivable financing

514.25%8.23M

-42.08%2.83M

541.90%4.2M

-24.20%4.73M

-85.13%1.34M

102.65%4.88M

--653.69K

940.77%6.24M

--9.01M

--2.41M

Other current assets

57.59%4.21M

47.94%5.11M

-6.89%4.19M

-70.47%3.29M

-68.99%2.67M

137.33%3.46M

--4.5M

1,133.86%11.13M

--8.62M

-86.88%1.46M

Total current assets

-3.36%1.63B

-0.06%1.65B

3.56%1.65B

8.49%1.68B

8.68%1.69B

219.35%1.65B

--1.6B

246.72%1.54B

--1.55B

38.50%516.6M

Non Current assets

Other non-current financial assets

425.32%26.27M

--26.27M

--25M

--5M

----

Investment real estate

-11.05%2M

-10.75%2.07M

-10.47%2.13M

-10.20%2.19M

-9.95%2.25M

-9.71%2.32M

--2.38M

-9.26%2.44M

--2.5M

-8.85%2.56M

Fixed assets

----

1.22%394.47M

----

0.92%412.74M

----

8.19%389.72M

----

12.35%408.98M

Constru in process

----

-90.53%1.59M

----

-96.45%431.62K

----

-73.24%16.82M

----

-30.78%12.17M

Intangible assets

-3.30%20.98M

-3.32%21.24M

-4.96%21.18M

-5.13%21.43M

-3.65%21.7M

-0.46%21.97M

--22.29M

0.48%22.59M

--22.52M

-2.74%22.07M

Long deferred expense

--4.23M

--4.55M

--4.93M

--5.25M

----

Deferred tax assets

--6.8K

205.37%5.99K

----

-99.88%1.96K

--2.79M

56.18%1.99M

--1.67M

19.14%1.61M

Usufruct assets

-23.08%2.14M

-21.82%2.3M

-19.73%2.46M

--2.63M

--2.79M

--2.95M

--3.07M

----

Other non current assets

253.46%41.25M

212.02%25.51M

295.88%10.61M

101.14%16.69M

90.40%11.67M

29.57%8.18M

--2.68M

97.16%8.3M

--6.13M

-7.22%6.31M

Total non current assets

5.71%474.02M

4.16%467.26M

2.89%461M

1.67%449.25M

0.95%448.43M

-1.13%448.58M

--448.05M

-2.61%441.86M

--444.23M

9.26%453.71M

Total assets

-1.45%2.1B

0.84%2.12B

3.42%2.11B

6.97%2.12B

6.96%2.13B

116.26%2.1B

120.94%2.04B

120.91%1.99B

143.75%2B

23.10%970.31M

Liabilities

Current liabilities

Short term loan

----

--18.56M

--18.58M

Transactional financial liabilities

----

-98.93%23.81K

-96.91%351.45K

-60.27%2.02M

2,828.81%615.97K

--2.22M

--11.39M

--5.08M

--21.03K

----

Notes payable and accounts payable

-26.43%78.38M

-26.03%84.97M

-23.02%84.72M

4.15%103.04M

-2.33%106.54M

-8.08%114.86M

--110.05M

-13.06%98.94M

--109.08M

37.53%124.96M

-Notes payable

-9.72%40.03M

0.83%39.28M

55.99%38.88M

26.30%43.67M

-9.99%44.34M

-25.60%38.96M

--24.92M

-21.78%34.57M

--49.26M

23.04%52.37M

-Accounts payable

-38.34%38.35M

-39.81%45.68M

-46.15%45.84M

-7.76%59.37M

3.97%62.2M

4.56%75.9M

--85.13M

-7.52%64.36M

--59.82M

50.30%72.59M

Contract liabilities

-8.76%2.19M

-68.08%2.07M

-23.83%3.5M

-26.55%3.93M

-63.10%2.4M

-3.50%6.49M

--4.6M

-22.54%5.35M

--6.49M

92.70%6.73M

Salaries payable

-12.97%9.12M

9.97%18.66M

6.00%17.63M

9.01%13.68M

11.76%10.48M

16.47%16.97M

--16.63M

27.11%12.55M

--9.38M

10.54%14.57M

Taxs payable

-82.57%1.95M

-56.06%2.16M

-33.73%2.09M

-14.74%7.52M

17.46%11.19M

5.35%4.91M

--3.16M

15.81%8.81M

--9.53M

637.21%4.66M

Other payable (including interest and dividends)

0.89%736.41K

6.96%768.49K

5.16%749.15K

5.53%744.89K

-9.71%729.93K

-10.37%718.5K

--712.38K

-11.73%705.83K

--808.4K

1.52%801.61K

-Interest payable

----

--11.27K

----

-Other payable

----

5.53%744.89K

----

-10.37%718.5K

----

-11.73%705.83K

----

1.52%801.61K

Non current liabilities due within one year

4.54%594.52K

4.54%587.95K

--581.46K

--575.04K

--568.69K

--562.41K

----

Other current liabilities

-0.93%2.91M

-9.71%2.87M

9.94%3.1M

8.93%3.12M

4.41%2.93M

10.45%3.18M

--2.82M

5.34%2.87M

--2.81M

41.75%2.88M

Total current liabilities

-29.22%95.88M

-25.22%112.1M

-24.53%112.73M

0.24%134.63M

-13.55%135.45M

-13.43%149.91M

--149.37M

-16.21%134.31M

--156.68M

56.03%173.17M

Current liabilities

Deferred tax liabilities

-3.43%20.59M

0.95%21.41M

9.10%22.52M

23.28%21.76M

22.53%21.32M

18.62%21.21M

--20.64M

13.22%17.65M

--17.4M

14.00%17.88M

Long term deferred income

-8.10%34.55M

-8.08%35.27M

4.42%36.05M

4.75%36.82M

5.06%37.6M

5.37%38.38M

--34.52M

-6.71%35.16M

--35.79M

-6.49%36.42M

Lease liabilities

-28.19%1.51M

-26.09%1.67M

-37.76%1.82M

--1.96M

--2.11M

--2.25M

--2.92M

----

Total non current liabilities

-7.16%56.66M

-5.64%58.35M

3.97%60.39M

14.66%60.55M

14.75%61.03M

13.88%61.84M

--58.08M

-0.88%52.81M

--53.19M

-0.61%54.3M

Total liabilities

-22.36%152.54M

-19.50%170.45M

-16.55%173.12M

4.31%195.18M

-6.38%196.49M

-6.91%211.75M

-4.08%207.45M

-12.39%187.11M

24.01%209.87M

37.35%227.47M

Shareholders equity

Paid-in capital

0.00%91.67M

33.34%91.67M

--91.67M

33.34%91.67M

--91.67M

0.00%68.75M

Capital reserve funds

0.00%1.14B

599.83%1.14B

--1.14B

599.83%1.14B

--1.14B

0.00%163.42M

Surplus reserve funds

0.00%46.79M

--46.79M

0.00%46.79M

--46.79M

0.00%46.79M

Retained profit

2.01%669.33M

9.76%663.54M

18.79%658.51M

25.23%647.7M

30.23%656.13M

30.32%604.53M

--554.35M

27.19%517.22M

--503.81M

34.97%463.89M

Less:Treasury stock

--252.43K

----

Shareholders equity without minority interests

0.67%1.95B

3.13%1.95B

5.67%1.94B

7.25%1.93B

8.53%1.94B

153.97%1.89B

159.09%1.84B

162.44%1.8B

174.95%1.79B

19.31%742.84M

Total shareholder equity

0.67%1.95B

3.13%1.95B

5.67%1.94B

7.25%1.93B

8.53%1.94B

153.97%1.89B

159.09%1.84B

162.44%1.8B

174.95%1.79B

19.31%742.84M

Total liabilityies and equity

-1.45%2.1B

0.84%2.12B

3.42%2.11B

6.97%2.12B

6.96%2.13B

116.26%2.1B

120.94%2.04B

120.91%1.99B

143.75%2B

23.10%970.31M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Rong Shing Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Money funds	38.55%428.08M	34.68%349.74M	11.74%346.81M	-36.26%229M	-76.86%308.97M	-21.79%259.69M	--310.36M	19.78%359.25M	--1.34B	238.51%332.06M
Transactional financial assets	-16.57%969.42M	-7.87%1.07B	-0.25%1.07B	22.87%1.21B	5,103.52%1.16B	5,271.44%1.16B	--1.07B	6,807,930.50%982.63M	--22.33M	-81.99%21.61M
Notes receivable and accounts receivable	-18.65%62.91M	-34.79%60.09M	-6.56%67.63M	-1.90%80.55M	-20.04%77.33M	7.82%92.14M	--72.38M	5.98%82.11M	--96.71M	7.18%85.46M
-Accounts receivable	-18.65%62.91M	-34.79%60.09M	-6.56%67.63M	-1.90%80.55M	-20.04%77.33M	7.82%92.14M	--72.38M	5.98%82.11M	--96.71M	7.18%85.46M
Other receivables (including interest and dividends)	5.28%989.06K	9.33%932.92K	12.18%991.87K	168.95%1.03M	162.71%939.42K	-58.40%853.3K	--884.2K	-35.63%381.35K	--357.58K	41.74%2.05M
-Other receivable	----	----	----	168.95%1.03M	----	-58.40%853.3K	----	-35.63%381.35K	----	41.74%2.05M
Advance payment	-21.98%2.88M	-31.85%3.47M	-16.89%2.97M	54.63%4.09M	30.22%3.69M	72.49%5.1M	--3.57M	33.23%2.65M	--2.83M	18.52%2.95M
Inventories	18.22%152.96M	28.04%157.09M	19.16%156.29M	45.43%145.7M	68.83%129.38M	78.85%122.69M	--131.16M	56.58%100.18M	--76.64M	14.11%68.6M
Receivable financing	514.25%8.23M	-42.08%2.83M	541.90%4.2M	-24.20%4.73M	-85.13%1.34M	102.65%4.88M	--653.69K	940.77%6.24M	--9.01M	--2.41M
Other current assets	57.59%4.21M	47.94%5.11M	-6.89%4.19M	-70.47%3.29M	-68.99%2.67M	137.33%3.46M	--4.5M	1,133.86%11.13M	--8.62M	-86.88%1.46M
Total current assets	-3.36%1.63B	-0.06%1.65B	3.56%1.65B	8.49%1.68B	8.68%1.69B	219.35%1.65B	--1.6B	246.72%1.54B	--1.55B	38.50%516.6M
Non Current assets
Other non-current financial assets	425.32%26.27M	--26.27M	--25M	--5M	--5M	----	----	----	----	----
Investment real estate	-11.05%2M	-10.75%2.07M	-10.47%2.13M	-10.20%2.19M	-9.95%2.25M	-9.71%2.32M	--2.38M	-9.26%2.44M	--2.5M	-8.85%2.56M
Fixed assets	----	----	----	1.22%394.47M	----	0.92%412.74M	----	8.19%389.72M	----	12.35%408.98M
Constru in process	----	----	----	-90.53%1.59M	----	-96.45%431.62K	----	-73.24%16.82M	----	-30.78%12.17M
Intangible assets	-3.30%20.98M	-3.32%21.24M	-4.96%21.18M	-5.13%21.43M	-3.65%21.7M	-0.46%21.97M	--22.29M	0.48%22.59M	--22.52M	-2.74%22.07M
Long deferred expense	--4.23M	--4.55M	--4.93M	--5.25M	----	----	----	----	----	----
Deferred tax assets	--6.8K	205.37%5.99K	----	----	----	-99.88%1.96K	--2.79M	56.18%1.99M	--1.67M	19.14%1.61M
Usufruct assets	-23.08%2.14M	-21.82%2.3M	-19.73%2.46M	--2.63M	--2.79M	--2.95M	--3.07M	----	----	----
Other non current assets	253.46%41.25M	212.02%25.51M	295.88%10.61M	101.14%16.69M	90.40%11.67M	29.57%8.18M	--2.68M	97.16%8.3M	--6.13M	-7.22%6.31M
Total non current assets	5.71%474.02M	4.16%467.26M	2.89%461M	1.67%449.25M	0.95%448.43M	-1.13%448.58M	--448.05M	-2.61%441.86M	--444.23M	9.26%453.71M
Total assets	-1.45%2.1B	0.84%2.12B	3.42%2.11B	6.97%2.12B	6.96%2.13B	116.26%2.1B	120.94%2.04B	120.91%1.99B	143.75%2B	23.10%970.31M
Liabilities
Current liabilities
Short term loan	----	----	----	----	----	----	----	----	--18.56M	--18.58M
Transactional financial liabilities	----	-98.93%23.81K	-96.91%351.45K	-60.27%2.02M	2,828.81%615.97K	--2.22M	--11.39M	--5.08M	--21.03K	----
Notes payable and accounts payable	-26.43%78.38M	-26.03%84.97M	-23.02%84.72M	4.15%103.04M	-2.33%106.54M	-8.08%114.86M	--110.05M	-13.06%98.94M	--109.08M	37.53%124.96M
-Notes payable	-9.72%40.03M	0.83%39.28M	55.99%38.88M	26.30%43.67M	-9.99%44.34M	-25.60%38.96M	--24.92M	-21.78%34.57M	--49.26M	23.04%52.37M
-Accounts payable	-38.34%38.35M	-39.81%45.68M	-46.15%45.84M	-7.76%59.37M	3.97%62.2M	4.56%75.9M	--85.13M	-7.52%64.36M	--59.82M	50.30%72.59M
Contract liabilities	-8.76%2.19M	-68.08%2.07M	-23.83%3.5M	-26.55%3.93M	-63.10%2.4M	-3.50%6.49M	--4.6M	-22.54%5.35M	--6.49M	92.70%6.73M
Salaries payable	-12.97%9.12M	9.97%18.66M	6.00%17.63M	9.01%13.68M	11.76%10.48M	16.47%16.97M	--16.63M	27.11%12.55M	--9.38M	10.54%14.57M
Taxs payable	-82.57%1.95M	-56.06%2.16M	-33.73%2.09M	-14.74%7.52M	17.46%11.19M	5.35%4.91M	--3.16M	15.81%8.81M	--9.53M	637.21%4.66M
Other payable (including interest and dividends)	0.89%736.41K	6.96%768.49K	5.16%749.15K	5.53%744.89K	-9.71%729.93K	-10.37%718.5K	--712.38K	-11.73%705.83K	--808.4K	1.52%801.61K
-Interest payable	----	----	----	----	----	----	----	----	--11.27K	----
-Other payable	----	----	----	5.53%744.89K	----	-10.37%718.5K	----	-11.73%705.83K	----	1.52%801.61K
Non current liabilities due within one year	4.54%594.52K	4.54%587.95K	--581.46K	--575.04K	--568.69K	--562.41K	----	----	----	----
Other current liabilities	-0.93%2.91M	-9.71%2.87M	9.94%3.1M	8.93%3.12M	4.41%2.93M	10.45%3.18M	--2.82M	5.34%2.87M	--2.81M	41.75%2.88M
Total current liabilities	-29.22%95.88M	-25.22%112.1M	-24.53%112.73M	0.24%134.63M	-13.55%135.45M	-13.43%149.91M	--149.37M	-16.21%134.31M	--156.68M	56.03%173.17M
Current liabilities
Deferred tax liabilities	-3.43%20.59M	0.95%21.41M	9.10%22.52M	23.28%21.76M	22.53%21.32M	18.62%21.21M	--20.64M	13.22%17.65M	--17.4M	14.00%17.88M
Long term deferred income	-8.10%34.55M	-8.08%35.27M	4.42%36.05M	4.75%36.82M	5.06%37.6M	5.37%38.38M	--34.52M	-6.71%35.16M	--35.79M	-6.49%36.42M
Lease liabilities	-28.19%1.51M	-26.09%1.67M	-37.76%1.82M	--1.96M	--2.11M	--2.25M	--2.92M	----	----	----
Total non current liabilities	-7.16%56.66M	-5.64%58.35M	3.97%60.39M	14.66%60.55M	14.75%61.03M	13.88%61.84M	--58.08M	-0.88%52.81M	--53.19M	-0.61%54.3M
Total liabilities	-22.36%152.54M	-19.50%170.45M	-16.55%173.12M	4.31%195.18M	-6.38%196.49M	-6.91%211.75M	-4.08%207.45M	-12.39%187.11M	24.01%209.87M	37.35%227.47M
Shareholders equity
Paid-in capital	0.00%91.67M	0.00%91.67M	0.00%91.67M	0.00%91.67M	0.00%91.67M	33.34%91.67M	--91.67M	33.34%91.67M	--91.67M	0.00%68.75M
Capital reserve funds	0.00%1.14B	0.00%1.14B	0.00%1.14B	0.00%1.14B	0.00%1.14B	599.83%1.14B	--1.14B	599.83%1.14B	--1.14B	0.00%163.42M
Surplus reserve funds	0.00%46.79M	0.00%46.79M	0.00%46.79M	0.00%46.79M	0.00%46.79M	0.00%46.79M	--46.79M	0.00%46.79M	--46.79M	0.00%46.79M
Retained profit	2.01%669.33M	9.76%663.54M	18.79%658.51M	25.23%647.7M	30.23%656.13M	30.32%604.53M	--554.35M	27.19%517.22M	--503.81M	34.97%463.89M
Less:Treasury stock	--252.43K	----	----	----	----	----	----	----	----	----
Shareholders equity without minority interests	0.67%1.95B	3.13%1.95B	5.67%1.94B	7.25%1.93B	8.53%1.94B	153.97%1.89B	159.09%1.84B	162.44%1.8B	174.95%1.79B	19.31%742.84M
Total shareholder equity	0.67%1.95B	3.13%1.95B	5.67%1.94B	7.25%1.93B	8.53%1.94B	153.97%1.89B	159.09%1.84B	162.44%1.8B	174.95%1.79B	19.31%742.84M
Total liabilityies and equity	-1.45%2.1B	0.84%2.12B	3.42%2.11B	6.97%2.12B	6.96%2.13B	116.26%2.1B	120.94%2.04B	120.91%1.99B	143.75%2B	23.10%970.31M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Rong Shing Certified Public Accountants (Special General Partnership)	--	--	--	Rong Shing Certified Public Accountants (Special General Partnership)	--	--	--	Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

301258 Suzhou Fushilai Pharmaceutical

Suzhou Fushilai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target